Alliance HealthCare Services, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services and radiation oncology services in the United States. The companys imaging services include magnetic resonance imaging (MRI) for evaluating soft tissue and organs, including the brain, spinal cord, and other internal anatomy; and positron emission tomography/computed tomography (PET/CT), which detects the metabolic signal of cancer cells and provides image of the internal anatomy. Its radiation oncology services comprise conventional beam therapy, 3-D conformal radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, stereotactic radiosurgery, low dose rate brachytherapy, and high dose rate brachytherapy for the treatment of cancer. Alliance HealthCare offers these services on a shared-service and full-time service basis, as well as through fixed-site imaging centers to hospitals and other healthcare providers. In addition, the company provides ancillary services consisting of marketing support, education, training, and billing assistance. AS of December 31, 2008, it had 505 diagnostic imaging and radiation oncology systems, including 301 MRI systems and 114 PET or PET/CT systems, and served approximately 1,000 clients in 46 states. Alliance HealthCare also operated 21 radiation oncology centers and stereotactic radiosurgery facilities. The company was formerly known as Alliance Imaging, Inc. and changed its name to Alliance HealthCare Services, Inc. in February 2009. Alliance HealthCare was founded in 1983 and is based in Newport Beach, California.

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific. Its programs under development pipeline include ARRY-403, a glucokinase activator for Type 2 diabetes, that is in a Phase 1 multiple ascending dose trial; ARRY-162, a MEK inhibitor for cancer that is in a Phase 1 trial; ARRY-380, an ErbB-2 inhibitor for breast cancer, which is in Phase 1 dose escalation trial; and ARRY-520, a KSP inhibitor that is in Phase 1 expansion trial in solid tumors and Phase 1/2 acute myeloid leukemia and multiple myeloma trials. The companys programs also comprise ARRY-614, a p38/Tie 2 dual inhibitor, which is in Phase 1 trial in myelodysplastic syndrome patients; ARRY-543, an ErbB family (ErbB-2/EGFR) inhibitor for solid tumors that is in Phase 1b combination trials; ARRY-797, a p38 inhibitor for subacute pain and cancer supportive care indications; and ARRY-300, an MEK that completed Phase 1 trial in healthy volunteers. It has collaborations with Celgene Corporation focusing on the discovery, development, and commercialization of novel therapeutics in cancer and inflammation; Genentech, Inc. to develop cancer programs; and AstraZeneca, PLC, which licensed the companys three MEK inhibitors for cancer, including AZD6244 (ARRY-886). The company was founded in 1998 and is headquartered in Boulder, Colorado.

BioClinica, Inc. operates as a global provider of clinical trials services, helping to support drug and product development efforts through various phases of the clinical trial process. BioClinica, created from the acquisition of Phoenix Data Systems, Inc. by Bio-Imaging Technologies, Inc., offers medical image.. Read More

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services primarily in the greater New York metropolitan area. It offers various chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radioimmuno analysis, toxicology, pap smears, tissue.. Read More

Clarient, Inc. provides oncology diagnostics services to community pathologists, biopharmaceutical companies, and researchers in the United States. It provides various cancer diagnostic and consultative services, including technical laboratory services and professional interpretation, such as reports and analyses.. Read More

Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families in the United States. It also engages in collecting, processing, and preserving peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem.. Read More

Covance Inc., a drug development services company, provides early-stage and late-stage product development services primarily to the pharmaceutical, biotechnology, and medical device industries worldwide. Its early stage development services include preclinical services, such as toxicology, pharmaceutical and nutritional chemistry, polyclonal and monoclonal antibody services, and bioanalytical services; and clinical pharmacology services, including first-in-human trials of new pharmaceuticals. The companys late stage development services include central laboratory services, including biomarker services to biotechnology and pharmaceutical customers; clinical development services comprising the full management of Phase II and III clinical studies, study design and modeling, study orchestration, trial logistics, enablement of study site performance, clinical data management and biostatistical analysis, and medical writing and regulatory services; clinical trial support services that include cardiac safety services; and commercialization services, such as periapproval services and market access services. It also offers laboratory testing services to the chemical, agrochemical, and food industries. The company was founded in 1987 and is based in Princeton, New Jersey.

CytoGenix, Inc., a biopharmaceutical company, focuses on the development and commercialization of its technology for identifying and silencing disease causing genes and expressing proteins for applications, such as vaccines and isolating novel nucleic acid-based anti-microbial compounds. Its technologies include.. Read More

Diagnostic Corporation of America does not have significant operations. The company intends to acquire an entity that provides wireless patient information systems to physicians and health care providers. Previously, it focused on marketing and leasing diagnostic medical equipment. The company was incorporated as.. Read More

Diagnostic Imaging International Corp., through its subsidiary Canadian Teleradiology Services, Inc., provides remote radiology (teleradiology) technology to hospitals and practices in Ontario, Canada. The company offers diagnostic imaging services. It specializes in MRI, CT, PET, US, NM, MAMMO, X-Ray, and BMD.. Read More

Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Enzo Life Sciences, Enzo Clinical Labs,.. Read More

eResearchTechnology, Inc. provides technology and services that enable the pharmaceutical, biotechnology, and medical device industries worldwide to collect, interpret, and distribute cardiac safety and clinical data. Its cardiac safety products and services include EXPERT, a technology platform that provides for.. Read More

GeneLink, Inc., through its subsidiaries, operates as a biosciences company that provides genetically-guided health, beauty, and wellness products to nutraceutical, personal care, and skin care industries in the United States. It offers a deoxyribonucleic acid (DNA) collection kit for the collection of DNA.. Read More

Genomic Health, Inc. operates as a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. The company launched the Oncotype DX breast cancer test, which has been.. Read More

Genoptix, Inc. provides specialized laboratory service that focus on delivering diagnostic services in the United States. Its services include COMPASS service offering, in which the companys hematopathologists determine the appropriate diagnostic tests to be performed, and then integrates patient history and.. Read More

Grant Life Sciences, Inc., a development stage company, engages in the development of protein-based screening tests to screen women for cervical cancer and pre-cancerous conditions. The company's tests detect the presence of various antibodies that appear when cervical cancer or pre-cancerous conditions are.. Read More

Healthcare Providers Direct, Inc. engages in the sale and distribution of diagnostic tests to physician offices and other healthcare providers in the United States. Its novel diagnostic tests include Uni-Gold Recombigen HIV 1 Test, a 10-minute test performed from a simple whole-blood finger stick; ImmunoDip Test.. Read More

Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements. The companys Professional Diagnostics segment offers preventive and interventional medical test products in the areas, such as cardiology, women's health, oncology, infectious disease, and drugs of abuse. Its Health Management segment provides wellness programs, including health and productivity assessment, healthy living programs, health portal and personal health record, and health coaching and risk screenings; disease management program; oncology program; and obstetrical care services, and home-based obstetrical programs. The companys Consumer Diagnostics segment offers a range of consumer products, including home diagnostic tests, cholesterol tests, glucose products, and treatment for bacterial vaginosis. Its vitamins and Nutritional Supplements segment offers vitamins and nutritional supplements, including Stresstabs, a B-complex vitamin with added antioxidants; Ferro-Sequels, a time-release iron supplement; Protegra, an antioxidant vitamin and mineral supplement; Posture-D, a calcium supplement; SoyCare, a soy supplement for menopause; ALLBEE, a line of B-complex vitamins; and Z-BEC, a zinc supplement with B-complex vitamins and added antioxidants. The company sells and markets its products through sales forces, distributors, and channel partners to hospitals, reference laboratories, physicians offices and other point-of-care settings, self-insured employers, pharmaceutical companies, retail drug stores, groceries, mass merchandisers, and warehouse clubs. It has operations in the United States, Canada, the United Kingdom, Germany, Italy, Spain, the Netherlands, France, Austria, India, Japan, China, Australia, South Africa, Brazil, Colombia, and Israel. The company was founded in 2001 and is headquartered in Waltham, Massachusetts.

Laboratory Corporation of America Holdings, together with its subsidiaries, operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The companys specialty tests and related services comprise viral load testing, and HIV genotyping and phenotyping for infectious diseases; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology testing; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on new drugs; forensic identity testing used in criminal proceedings and parentage evaluation services; allergy testing consisting of a range of allergen testing services, computerized analysis, and treatment program that enables primary care physicians to diagnose and treat various allergic disorders; and occupational testing services, which include urine and blood testing services for the detection of drug and alcohol abuse for private and government customers. Its customers comprise physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. As of December 31, 2008, the company operated 36 primary laboratories and approximately 1,600 patient service centers. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Medasorb Technologies Corporation, a development stage medical device company, focuses on developing and commercializing blood purification technologies that would remove middle molecular weight toxins from circulating blood and physiologic fluids. Its products include CytoSorb device, which is intended to remove.. Read More

Medistem, Inc., a biotechnology company, engages in the discovery, development, and commercialization of technologies related to adult stem cell extraction and manipulation for use in the treatment of inflammatory and degenerative diseases in the United States. Its lead product, the endometrial regenerative cell.. Read More

MEDTOX Scientific, Inc. and its subsidiaries provide forensic and clinical laboratory services. It also manufactures and distributes diagnostic and related devices. The Laboratory Services segment offers workplace drug-of-abuse testing services. Its services include pediatric lead testing; heavy metal, trace.. Read More

Micro Imaging Technology, Inc. develops fluid monitoring systems for water monitoring, food processing, and clinical applications in the United States. The companys laser-based rapid microbe detection system determines the specific specie of an unknown microbe present in a fluid. Its customers include water.. Read More

Nanobac Pharmaceuticals, Incorporated, a bio-lifescience company, engages in the discovery and development of products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays,.. Read More

National Dentex Corporation engages in the design, fabrication, marketing, and sale of custom dental prosthetic appliances for and to dentists. The company offers restorative, reconstructive, and cosmetic products. Its restorative products comprise crowns and bridges; and various porcelain jackets, which are crowns constructed of porcelain; onlays, which are partial crowns that do not cover full visible tooth; precision crowns, which are restorations to receive and connect a removable partial denture; and inlays, which are restorations made to fit a prepared tooth cavity and then cemented into place. The companys reconstructive products include partial dentures that are removable dental prostheses, which replace missing teeth and associated structures; and full dentures, which dental prostheses that substitute for the loss of teeth and associated structures. Its cosmetic products primarily comprise porcelain veneers that are coverings of porcelain cemented to the front of a tooth to enhance personal appearance; and ceramic crowns, which are crowns made from ceramic materials that replicate natural teeth. The company also sells precision attachments, which connect a crown and an artificial prosthesis; implants which are fixtures anchored in the bone of the mouth to which a crown, partial, or full denture is secured; and composite inlays and onlays, which replace silver fillings, as well as orthodontic appliances to move existing teeth to enhance function and appearance. As of December 31, 2008, it owned and operated 46 dental laboratories, comprising of 41 full-service dental laboratories and 5 branch laboratories in the United States and Canada. The company was formerly known as H&M Laboratories Services, Inc. and changed its name to National Dentex Corporation in 1983. National Dentex Corporation was founded in 1982 and is based in Natick, Massachusetts.

NeoGenomics, Inc., doing business as NeoGenomics Laboratories, operates a network of cancer-focused testing laboratories in the United States. The company provides various testing services, including cytogenetics testing, which analyzes human chromosomes; Fluorescence In-Situ Hybridization testing that analyzes.. Read More

Pacific Biometrics, Inc. provides specialty reference and clinical laboratory services primarily to the pharmaceutical, biotechnology, and diagnostics industries in the United States. The companys services support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research,.. Read More

Pharmaceutical Product Development, Inc. (PPD), a contract research organization, provides drug discovery and development services, post-approval expertise, and compound partnering programs. The company operates in two segments: Discovery Sciences and Development. The Discovery Sciences segment offers various preclinical services, including preclinical program design, preclinical oncology research models, toxicology consulting, laboratory services, and technical writing and regulatory submissions; biomarker discovery and patient sample analysis; and compound collaboration programs. The Development segment provides a range of development services, including strategic product development solutions; Phase I clinical testing; laboratory services, such as testing services with customized results databases for pharmaceutical and biotechnology companies engaged in clinical drug development, as well as government-funded studies; and Phases II-IV clinical trial management services primarily comprising study protocol and case report form design, site and investigator recruitment, patient enrollment and study feasibility, interactive voice and/or Web response systems, investigative product services, study monitoring and data collection, government services, data management and biostatistical analysis, medical writing and regulatory services, and post-approval services. The company also offers support services, such as product launch services, medical information, patient compliance programs, patient and disease registry programs, product safety and pharmacovigilance, Phase IV monitored studies, and prescription-to-over-the-counter programs. PPDs clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. It operates in the Americas, Europe, Africa, the Middle East, and the Asia Pacific. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.

Protein Polymer Technologies, Inc., a biotechnology company, engages in the research, development, and production of bio-active devices to improve medical and surgical outcomes. The company, through its proprietary technology, produces molecular weight polymers that can be processed into a range of material.. Read More

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples primarily in the United States. The company provides commercial testing and confirmation by mass spectrometry to detect the presence of drugs of abuse, such as cocaine, marijuana, and PCP; methamphetamine, including ecstasy; and opiates that include heroin, hydrocodone, hydromorphone, and oxycodone. Its tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug used over a period of time. The company serves employers for applicant and employee testing, as well as physicians, treatment professionals, law enforcement agencies, school administrators, parents concerned about their childrens drug use, and other individuals or entities engaged in business where drug use or potential drug use is an issue. Psychemedics primarily markets its corporate drug testing services through its own sales force; and home drug testing services through the Internet and retail distributors. The company was founded in 1985 and is based in Acton, Massachusetts.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It provides patients and physicians the access to diagnostic laboratory services through its network of laboratories and owned patient service centers; and interpretive consultation. The.. Read More

RadNet, Inc. operates a group of regional networks of diagnostic imaging facilities in the United States. Its imaging centers provide various diagnostic imaging services, including magnetic resonance imaging or MRI, computed tomography or CT, positron emission tomography or PET, nuclear medicine, mammography,.. Read More

Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. The company develops products for the treatment for Type 2 diabetes. Its product pipeline includes Naturlose, which is in Phase III clinical trials for the treatment of Type 2 diabetes. The company also provides.. Read More

Stem Cell Therapy International, Inc. operates in the field of regenerative medicine. The company focuses on the treatment of patients with stem cell transplantation therapy, as well as on the provision of biological solutions containing new lines of stem cell products. It offers allo (human) stem cell biological.. Read More